Cellular Classification of Breast Cancer
The following is a list of breast cancer histologic classifications.[1] Infiltrating or invasive ductal cancer is the most common breast cancer histologic type and comprises 70% to 80% of all cases.
- Carcinoma, NOS (not otherwise specified).
- Ductal.
- Intraductal (in situ).
- Invasive with predominant intraductal component.
- Invasive, NOS.
- Comedo.
- Inflammatory.
- Medullary with lymphocytic infiltrate.
- Mucinous (colloid).
- Papillary.
- Scirrhous.
- Tubular.
- Other.
- Lobular.
- In situ.
- Invasive with predominant in situ component.
- Invasive.[2]
- Nipple.
- Paget disease, NOS.
- Paget disease with intraductal carcinoma.
- Paget disease with invasive ductal carcinoma.
- Other.
- Undifferentiated carcinoma.
The following are tumor subtypes that occur in the breast but are not considered to be typical breast cancers:
Christina Applegate Seeks Early Detection for Breast Cancer
Cancer didn't catch Christina Applegate unprepared. Because her mother had battled both breast cancer and ovarian cancer, Applegate had been going for regular mammograms since the age of 30. "But when I turned 36, my doctor said that my breasts were just too dense for mammography alone, and he referred me for screening MRIs at Cedars-Sinai Medical Center," she recalls. Just a few months before she learned she herself had breast cancer, the actor got a shocking insight into the struggles faced...
Read the Christina Applegate Seeks Early Detection for Breast Cancer article > >
References:
- Breast. In: Edge SB, Byrd DR, Compton CC, et al., eds.: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer, 2010, pp 347-76.
- Yeatman TJ, Cantor AB, Smith TJ, et al.: Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann Surg 222 (4): 549-59; discussion 559-61, 1995.
- Chaney AW, Pollack A, McNeese MD, et al.: Primary treatment of cystosarcoma phyllodes of the breast. Cancer 89 (7): 1502-11, 2000.
- Carter BA, Page DL: Phyllodes tumor of the breast: local recurrence versus metastatic capacity. Hum Pathol 35 (9): 1051-2, 2004.
WebMD Public Information from the National Cancer Institute
